Dosing considerations for TRELEGY:
- Administer as one inhalation, once daily. Take at the same time every day and use only once every 24 hours.
- Instruct patients to rinse their mouths with water after inhalation to reduce the risk of oropharyngeal candidiasis.
Features of TRELEGY ELLIPTA, an easy-to-use8 inhaler
3 medications. 1 inhaler. 1 daily inhalation.
Requires no hand-breath coordination
Each inhaler contains 30 doses
Single-Step Dose Activation
A dose is ready when the cover is opened fully. Counter automatically keeps track of remaining doses.
For more information, see the Instructions for Use in the Patient Information for TRELEGY.
The TRELEGY ELLIPTA inhaler contains two 30-blister foil strips:
- Strip 1 contains fluticasone furoate (100 mcg per blister)
- Strip 2 contains a blend of umeclidinium (62.5 mcg per blister) and vilanterol (25 mcg per blister)
- Also contains inactive ingredients: lactose monohydrate and magnesium stearate
At the conclusion of a 4-week, open-label, placebo study of patients with COPD (N=266), 93% demonstrated correct use and rated the inhaler easy to use.8 Inhalers did not contain active treatment.
Inhalers did not contain active treatment
Design: A 28-day, open-label, placebo study designed to assess ease of use of the ELLIPTA inhaler in patients with COPD (N=266), among patients using the inhaler correctly on Day 28. Correct use was evaluated using instructions derived from the prescribing information for products delivered in the ELLIPTA inhaler. At enrollment, patients were allowed up to 3 attempts to demonstrate correct use (with training between attempts 1 and 2, and 2 and 3, if necessary), and all patients were able to demonstrate correct use. On Day 28, patients were evaluated for correct use in a single attempt without additional instruction. 97% demonstrated correct use. “Easy to use” was defined as a rating of very easy or easy on a 4-point scale (very easy, easy, difficult, very difficult).
The GOLD 2020 Report
According to GOLD 2020, use of multiple inhalers is one factor that may lead to poor inhaler technique.9
TRELEGY does not replace a rescue inhaler. Acute symptoms should be treated with an inhaled short-acting beta2-agonist.
Explore the clinical data for once-daily TRELEGYView Now